Shafa Orthopedic Journal

Published by: Kowsar

Optimal Timing and Antibiotic Prophylaxis in Periprosthetic Joint Infection: Literature Review and World Consensus (Part Four)

Javad Parvizi 1 , * , Mohammad Ghazavi 2 and Members of Preop Antibiotics Committee of the Consensus Meeting 3
Authors Information
1 Rothman Institute, Thomas Jefferson University, Philadelphia, PA, USA
2 Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, IR Iran
3 William Arnold MD PhD; Katherine Belden MD; Goran Bicanic; Stefano Bini MD; Fabio Catani MD; Jiying Chen MD PhD; Mohammad Ghazavi MD FRCSC; Karine M. Godefroy MD; Erik Hansen MD; Paul Holham MD; Hamid Hosseinzadeh MD; Kang II Kim MD; Klaus Kirketerp-Moller MD; Lars Lidgren MD PhD; Jian Hao Lin MD; Jess H. Lonner MD; Christopher Moore MD; Panayiotis Papagelopoulos MD; Lazaros Poultsides MD MSc PhD; Khalid Saleh MD MSC FRCSC MHCM; Julia V Salmon MD; Edward Schwarz PhD; Randi Silibovsky MD (US); Jose Stuyck MD; Markus Vogt MD (International); Annette W. Dahl MD; Koji Yamada MD
Article information
  • Shafa Orthopedic Journal: November 28, 2015, 2 (4); e3052
  • Published Online: November 29, 2015
  • Article Type: Review Article
  • Received: June 20, 2015
  • Accepted: June 24, 2015
  • DOI: 10.17795/soj-3052

To Cite: Parvizi J, Ghazavi M, Committee of the Consensus Meeting M O P A. Optimal Timing and Antibiotic Prophylaxis in Periprosthetic Joint Infection: Literature Review and World Consensus (Part Four), Shafa Ortho J. 2015 ;2(4):e3052. doi: 10.17795/soj-3052.

Abstract
Copyright © 2015, Iran University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
References
  • 1. Turano A. New clinical data on the prophylaxis of infections in abdominal, gynecologic, and urologic surgery. Multicenter Study Group. Am J Surg. 1992; 164(4A Suppl): 16S-20S[PubMed]
  • 2. Niederhauser U, Vogt M, Vogt P, Genoni M, Kunzli A, Turina MI. Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovasc Surg. 1997; 114(2): 162-8[PubMed]
  • 3. Wymenga AB, Hekster YA, Theeuwes A, Muytjens HL, van Horn JR, Slooff TJ. Antibiotic use after cefuroxime prophylaxis in hip and knee joint replacement. Clin Pharmacol Ther. 1991; 50(2): 215-20[PubMed]
  • 4. McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998; 68(6): 388-96[PubMed]
  • 5. Mauerhan DR, Nelson CL, Smith DL, Fitzgerald RH, Slama TG, Petty RW. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. J Bone Joint Surg Am. 1994; 76(1): 39-45
  • 6. Heydemann JS, Nelson CL. Short-term preventive antibiotics. Clin Orthop Relat Res. 1986; (205): 184-7[PubMed]
  • 7. Stone HH, Haney BB, Kolb LD, Geheber CE, Hooper CA. Prophylactic and preventive antibiotic therapy: timing, duration and economics. Ann Surg. 1979; 189(6): 691-9[PubMed]
  • 8. Williams DN, Gustilo RB. The use of preventive antibiotics in orthopaedic surgery. Clin Orthop Relat Res. 1984; (190): 83-8[PubMed]
  • 9. Tang WM, Chiu KY, Ng TP, Yau WP, Ching PT, Seto WH. Efficacy of a single dose of cefazolin as a prophylactic antibiotic in primary arthroplasty. J Arthroplasty. 2003; 18(6): 714-8[PubMed]
  • 10. Sharma D, Douglas J, Coulter C, Weinrauch P, Crawford R. Microbiology of infected arthroplasty: implications for empiric peri-operative antibiotics. J Orthop Surg (Hong Kong). 2008; 16(3): 339-42[PubMed]
  • 11. Nickinson RS, Board TN, Gambhir AK, Porter ML, Kay PR. The microbiology of the infected knee arthroplasty. Int Orthop. 2010; 34(4): 505-10[DOI][PubMed]
  • 12. Bengston S, Knutson K, Lidgren L. Treatment of infected knee arthroplasty. Clin Orthop Relat Res. 1989; (245): 173-8[PubMed]
  • 13. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001; (392): 15-23[PubMed]
  • 14. Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am. 2000; 82-A(11): 1552-7[PubMed]
  • 15. Rafiq I, Gambhir AK, Wroblewski BM, Kay PR. The microbiology of infected hip arthroplasty. Int Orthop. 2006; 30(6): 532-5[DOI][PubMed]
  • 16. Al-Maiyah M, Hill D, Bajwa A, Slater S, Patil P, Port A, et al. Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br. 2005; 87(9): 1256-8[DOI][PubMed]
  • 17. Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006; 88(7): 943-8[DOI][PubMed]
  • 18. Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am. 2006; 88(6): 1231-7[DOI][PubMed]
  • 19. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996; 78(4): 512-23[PubMed]
  • 20. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect. 2007; 55(1): 1-7[DOI][PubMed]
  • 21. Azzam K, McHale K, Austin M, Purtill JJ, Parvizi J. Outcome of a second two-stage reimplantation for periprosthetic knee infection. Clin Orthop Relat Res. 2009; 467(7): 1706-14[DOI][PubMed]
  • 22. Kalra KP, Lin KK, Bozic KJ, Ries MD. Repeat 2-stage revision for recurrent infection of total hip arthroplasty. J Arthroplasty. 2010; 25(6): 880-4[DOI][PubMed]
  • 23. Jamsen E, Stogiannidis I, Malmivaara A, Pajamaki J, Puolakka T, Konttinen YT. Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop. 2009; 80(1): 67-77[DOI][PubMed]
  • 24. Kubista B, Hartzler RU, Wood CM, Osmon DR, Hanssen AD, Lewallen DG. Reinfection after two-stage revision for periprosthetic infection of total knee arthroplasty. Int Orthop. 2012; 36(1): 65-71[DOI][PubMed]
  • 25. Mortazavi SMJ, O'Neil JT, Zmistowski B, Parvizi J, Purtill JJ. Repeat 2-stage exchange for infected total hip arthroplasty: a viable option? J Arthroplasty. 2012; 27(6): 923-926. e1
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments